By contrast to CCL18, CXCL5 levels in MS and MR macrophages were remarkably high and the difference was statistically significant (Fig. 5E, F; HGC27: p < 0.001; MKN45: p < 0.001). This evidence concerns the gene CXCL5 and myeloid sarcoma.